Asia Fresh News

Asia Fresh Stories

Archive for July 12th, 2016

Frost & Sullivan Applauds Improved Efficiencies of Agfa HealthCare’s MUSICA® Image Processing Software for the Digital Radiography Market

leave a comment »

The company is the vendor of choice among radiography imaging providers owing to its superior products and unmatched competencies in improving customers’ standard of care

MOUNTAIN VIEW, California/PRNewswire/ — Based on its recent analysis of the digital radiography (DR) market, Frost & Sullivan recognizes Agfa HealthCare with the 2016 North America Frost & Sullivan Award for Product Leadership. Agfa HealthCare’s dedication to facilitating quality outcomes and improved productivity in radiography has resulted in the unique MUSICA® technology, its patented image processing software. The company’s complete portfolio of digital, fixed, mobile, and retrofit DR systems, as well as impressive radiography advancements, have earned it a solid reputation for service excellence and product reliability.

Agfa HealthCare
Agfa HealthCare

MUSICA, which stands for Multi-Scale Image Contrast Amplification, is an image-processing algorithm that differentiates Agfa HealthCare’s DR solutions from its peers. This software optimizes and quality-controls images automatically, while competitors’ products require operators to manually adjust contrast, density, sharpness, and other elements to augment image quality.

“Now in its third generation, MUSICA is the engine that generates the crisp and detailed images produced by all of Agfa HealthCare’s radiography equipment,” said Frost & Sullivan Consultant Poornima Srinivasan. “The company offers standardized image quality, low dose imaging, and the best productivity across its imaging enterprise and radiography fleet.”

Testing with board certified Radiologists has determined that Cesium Bromide (CR) and Cesium Iodide (DR) Detectors when used with MUSICA processing can provide dose reductions between 50 to 60% when compared to traditional Barium Fluoro Bromide CR systems. This claim has been cleared by the US Food and Drug Administration (FDA) under the 510(k) pre-market process. Radiologists, administrators and technologists have been extremely satisfied with Agfa products’ image quality, dose efficiency, and workflow productivity. Agfa HealthCare works closely with its customers so they can extract optimum clinical, operational, and financial benefits from the company’s offerings. MUSICA algorithms have been developed with the help of dozens of radiologists reviewing thousands of clinical images.

Agfa HealthCare’s products support a wide range of radiography benefits, including fast procedure turnaround times, providing tools to support its customers’ patient safety goals, and low retake rates. In addition to being extremely well positioned in the high-to-premium radiography market segments, Agfa HealthCare also promotes its high quality medical imaging technology among cost-sensitive customers. This strategy is rooted in the company’s ability to deliver excellent return on investment through its consistent image quality, “right-the-first-time” imaging, and enhanced diagnostic insight.

Agfa HealthCare is among the top vendors globally, with 55,000 DR and computed radiography (CR) devices in operation as of 2015. Agfa’s DR portfolio accounted for nearly 25 percent of the company’s global healthcare revenue in 2015, with North America being one of the biggest contributors.

“Its in-house research and development capabilities, as well as its collaborations with research universities such as Oregon Health & Science University, have enabled Agfa HealthCare to sustain its value proposition,” noted Srinivasan. “These relationships have made its DR systems one of the fastest-adopted products in North America, with more than 2,000 DR installations over the last three years.”

Agfa HealthCare’s DR solutions are proven to have a significant impact on radiology workflow, and enterprise imaging performance. As the company continues to strengthen its sales and service network, it is poised to make the most of the current buying behaviors in the North American DR market.

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Agfa HealthCare

Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990’s. Today Agfa HealthCare designs, develops, and delivers state-of-the-art systems for capturing, managing, and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on “the next big thing”

Register:         Gain access to visionary innovation


Chiara Carella
P: +44 (0) 207.343.8314
F: 210.348.1003

Photo –

Source: Frost & Sullivan
Related Links:

Written by asiafreshnews

July 12, 2016 at 6:04 pm

Posted in Uncategorized

Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration Agreement for Development and Commercialization of Anti-PD-1 Antibody

leave a comment »

An Immuno-Oncology Therapy with Many Potential Applications

SAN DIEGO /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, and Servier, the largest non-listed pharmaceutical company in France, today announced a license and collaboration agreement for the development, manufacture and commercialization of products using Sorrento’s fully human immuno-oncology anti-PD-1 monoclonal antibody (mAb) STI-A1110.

Logo –
Logo –

Sorrento’s proprietary G-MAB library platform was used to identify and generate STI-A1110, which targets PD-1, one of the key targets in the rapidly developing immuno-oncology therapy market. The agreement provides Servier with an exclusive worldwide license to Sorrento’s STI-A1110 mAb asset, covering all indications including hematological and solid tumor cancers. Servier also obtains full rights to develop, register and commercialize the products and will bear all costs for these activities.

The financial terms of the agreement include, among other things, a non-refundable upfront payment to Sorrento of €25 million. Sorrento may also receive development milestone payments for the initial product and each additional product. Sorrento may receive up to €710 million in various payments based on commercial sales milestones related to annual net sales levels for the initial product and then also for each additional product. In addition to the commercial sales milestones, Sorrento will be entitled to receive variable royalties on the sales of all commercialized products ranging from high single-digit to double-digit percentages.

“We are excited about partnering on our anti-PD-1 immune checkpoint antibody with Servier, which is recognized for its scientific excellency and as a pioneer in CAR-T therapies. This agreement represents validation for Sorrento’s antibody technologies and R&D capabilities,” stated Dr. Henry Ji, President and CEO of Sorrento. “This also further establishes Sorrento as a notable immuno-oncology company with a comprehensive portfolio of clinical stage and preclinical immunotherapies. We look forward to working closely with the Servier team and growing this global partnership.”

“We have tested STI-A1110 in preclinical studies conducted at Servier and we believe that, used in combination with several products from our portfolio, it will lead to the development of new treatments for hematological as well as solid tumor cancers,” added Dr. Jean-Pierre Abastado, Director of the Oncology Innovation Therapeutic Pole for Servier.

About Sorrento Therapeutics, Inc. 

Sorrento is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento’s lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.

About Servier

Servier is a non-listed international pharmaceutical company headquartered in France. With a strong international presence in 148 countries and a turnover of 3.9 billion euro in 2015, Servier employs more than 21,200 people worldwide. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiology, oncology, metabolism, neuropsychiatry and rheumatology. Thanks to its governance placed in a non-profit Foundation, the Group reinvests 25% of Servier’s products turnover in Research and Development and all its profits in its growth.

Becoming a key player in oncology is part of Servier’s long-term strategy. Currently, there are nine new molecular entities in clinical development in this area, targeting breast and lung cancers, and other solid tumors, as well as various leukemias and lymphomas. This portfolio of innovative cancer treatments is being developed with partners worldwide, and covers different cancer hallmarks, including cytotoxics, proapoptotics, targeted, immune, and cellular therapies.

More information is available at

Forward-Looking Statements

This press release and any statements made for and during any presentation or meeting contain forward-looking statements related to Sorrento Therapeutics, Inc. and its subsidiaries under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995 and subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements regarding the exclusive license with Servier and related future milestones; Sorrento’s expectations for its technologies and collaborations; Sorrento’s and its subsidiaries’ prospects; and other matters that are described in Sorrento’s most recent periodic reports filed with the Securities and Exchange Commission, including Sorrento’s Annual Report on Form 10-K for the year ended December 31, 2015, as amended, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, including the risk factors set forth in those filings. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release and we undertake no obligation to update any forward-looking statement in this press release except as required by law.

Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.

All other trademarks and trade names are the property of their respective owners.

© 2016 Sorrento Therapeutics, Inc.  All Rights Reserved.

Source: Sorrento Therapeutics, Inc.

Related stocks: NASDAQ-SMALL:SRNE

Written by asiafreshnews

July 12, 2016 at 6:03 pm

Posted in Uncategorized

AMRI Completes Acquisition of Euticals

leave a comment »

ALBANY, N.Y. /PRNewswire/ — AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as “Euticals”, a privately-held company headquartered in Lodi, Italy, specializing in custom synthesis and the manufacture of active pharmaceutical ingredients (APIs). This completes the transaction initially announced on May 5, 2016.

The acquisition positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry, and in particular, provides the company with an established custom synthesis presence in key European markets.

“We are delighted to have Euticals join the AMRI family as we create an industry leader in global contract research and manufacturing. Euticals’ API platform is a significant addition to AMRI’s capabilities, and we are excited about the future opportunities our company will have as a result of this pivotal acquisition,” said William S. Marth, AMRI’s president and chief executive officer.

Mr. Marth added: “This significantly expands AMRI’s customer base, further diversifies our revenue streams, and moves us significantly closer to our goal of reaching $1 billion in annual revenues by 2018. The Euticals acquisition accelerates our company’s strategy to become a global, preeminent provider of contract research, development and manufacturing services to the pharmaceutical industry, while at the same time enhancing our ability to expertly serve our customers.

“As we prepare to celebrate AMRI’s 25th anniversary this year, the closing of this transaction is a timely achievement that I am confident will position AMRI for success over many years to come,” concluded Mr. Marth.

AMRI financed the EUR 315 million transaction through the issuance of approximately 7.1 million shares of AMRI common stock (valued at signing), seller notes totaling EUR 55 million and the remainder in cash. In connection with the acquisition, AMRI secured $235 million in incremental borrowings under its existing Senior Secured Revolving Credit Facility, which bears interest at LIBOR with a floor of 1% plus 475 basis points, and repaid its$30 million revolving credit facility. AMRI intends to provide updated 2016 financial guidance,  including the impact of the Euticals’ acquisition, in early August in conjunction with the company’s second quarter financial results.

The 7.1 million shares of AMRI common stock issued in connection with the transaction were offered and sold outside the United States to Lauro Cinquantesette S.p.A. (Lauro 57), the sole stockholder of Euticals and an eligible investor pursuant to Regulation S of the Securities Act of 1933, as amended. Such shares have not been registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration under or an applicable exemption from such registration requirements. This press release does not constitute an offer to sell, or a solicitation of an offer to purchase, the shares in any jurisdiction in which such offer or solicitation would be unlawful.

Nomura acted as exclusive financial advisor to AMRI in connection with this transaction and Goodwin Procter LLP and LCA Studio Legale acted as AMRI’s legal advisors. Lincoln International acted as sole financial advisor to Lauro 57, and Chiomenti Studio Legale and Debevoise & Plimpton LLP acted as Lauro 57’s legal advisors.

About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing (DPM). Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API supports the chemical development and cGMP manufacture of complex API, including potent and cytotoxic compounds, controlled substances, steroids, hormones, and sterile API. DPM supports development through commercial scale production of complex liquid-filled and lyophilized parenterals, sterile suspensions and ophthalmic formulations. For more information about AMRI, please visit our website at or follow us on Twitter (@amriglobal).

Forward Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws that involve risks and uncertainties. These statements include, but are not limited to, statements regarding the acquisition of Euticals and expectations as to its impact on AMRI’s business and strategy, including AMRI’s customer base, revenue streams and positioning as one of the largest independent developers and suppliers of API to the pharmaceutical industry, as well as AMRI’s goal of reaching $1 billion in annual revenues by 2018. Readers should not place undue reliance on our forward-looking statements. AMRI’s actual results may differ materially from such forward-looking statements as a result of numerous factors, some of which AMRI may not be able to predict and may not be within AMRI’s control. Factors that could cause such differences include, but are not limited to, the ability of AMRI to effectively integrate the Euticals business; possible negative impacts to the revenue expected to be received by the Euticals business; trends in pharmaceutical and biotechnology companies’ outsourcing of manufacturing services and chemical research and development, including softness in these markets; the success of the sales of other products for which AMRI receives royalties; the risk that clients may terminate or reduce demand under any strategic or multi-year deal; AMRI’s ability to enforce its intellectual property and technology rights; AMRI’s ability to obtain financing sufficient to meet its business needs; AMRI’s ability to successfully comply with heightened FDA scrutiny on aseptic fill/finish operations; the results of further FDA inspections; AMRI’s ability to effectively maintain compliance with applicable FDA and DEA regulations; AMRI’s ability to integrate past or future acquisitions,  and make such acquisitions accretive to AMRI’s business model, AMRI’s ability to take advantage of proprietary technology and expand the scientific tools available to it, the ability of AMRI’s strategic investments and acquisitions to perform as expected, as well as those risks discussed in AMRI’s Annual Report on Form 10-K for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on March 30, 2016, and AMRI’s other SEC filings.

Source: AMRI

Related stocks: Frankfurt:AYM NASDAQ-NMS:AMRI

Written by asiafreshnews

July 12, 2016 at 5:59 pm

Posted in Uncategorized

Build Brand Awareness by Pitching Influencers

leave a comment »

Latest article on PR Newswire’s Small Business PR Toolkit discusses influencer outreach

NEW YORK/PRNewswire/ — Utilizing storytelling through your marketing efforts is an excellent way for small businesses to build up their brand’s awareness. However, it takes more than just a brand voice to drive awareness and engagement. Forward-thinking brands recognize that consumers trust recommendations from connections over traditional brand promotions, so they are seeking out influencers in their industries and establishing relationships to turn them into brand advocates and, in some cases, even brand endorsers.

Logo –

In the latest article posted to the Small Business PR Toolkit, contributing author Penny Sansevieri gives a step-by-step approach to follow when pitching key influencers:

  • Identify. Not every influencer is an ideal fit for your brand, so consider networking to uncover new or existing relationships to nurture.
  • Research. Once you’ve identified the appropriate group of influencers, take the time to research these individuals to learn more about them and to also confirm their followers consist largely of individuals who match your target buyer personas.

For discussion on the remaining ways to build on your influencer outreach efforts, read the complete article here:

PR Newswire’s Small Business PR Toolkit is a comprehensive resource that provides small businesses and entrepreneurs the tools to develop an affordable public relations and marketing plan that helps generate interest from potential customers, engage with key audiences and grow their businesses. The toolkit features relevant content such as informative white papers, interactive webinars and how-to articles and premium access to educational resources, as well as the opportunity to take advantage of special offers designed specifically for small businesses. To request information on how PR Newswire can help your small business, click here. You can receive updates on new Small Business PR Toolkit content by following @prnsmallbiz on Twitter.

About PR Newswire
PR Newswire, a Cision company, is the premier global provider of multimedia platforms and distribution that marketers, corporate communicators, sustainability officers, public affairs and investor relations officers leverage to engage key audiences. Having pioneered the commercial news distribution industry over 60 years ago, PR Newswire today provides end-to-end solutions to produce, optimize and target content — and then distribute and measure results. Combining the world’s largest multi-channel, multi-cultural content distribution and optimization network with comprehensive workflow tools and platforms, PR Newswire powers the stories of organizations around the world. PR Newswire serves tens of thousands of clients from offices in the Americas, Europe, Middle East, Africa and Asia-Pacific regions.

Cision is a leading global media intelligence company, serving the complete workflow of today’s communication professionals.

Amanda Eldridge
Director, Strategic Channels

Source: PR Newswire Association LLC

Written by asiafreshnews

July 12, 2016 at 5:57 pm

Posted in Uncategorized

In Historic Win for Global Health, Uruguay Defeats Philip Morris Challenge to Its Strong Tobacco Control Laws

leave a comment »

Statements by Michael R. Bloomberg and Matthew L. Myers

WASHINGTON/PRNewswire/ — In a historic public health victory that will be felt around the world,Uruguay has won an international legal battle against Philip Morris International to uphold its strong laws to reduce tobacco use.

Logo –

More than six years after Philip Morris launched its legal attack, an arbitration tribunal of the World Bank today ruled in Uruguay’s favor and strongly rejected Philip Morris’ challenge to two laws adopted by Uruguay to reduce the death and disease caused by tobacco use. One law requires graphic warnings covering 80 percent of the front and back of cigarette packs, while the other limits each cigarette brand to one pack presentation in order to prevent the use of terms (such as “light” and “mild”) and colors to falsely imply that some cigarettes are less harmful.

Statement by Michael R. Bloomberg, Founder of Bloomberg Philanthropies and three-term Mayor of New York City

This is a major victory for the people of Uruguay – and it shows countries everywhere that they can stand up to tobacco companies and win. Governments should always be able to protect people’s health and safety, and we’re committed to helping them when tobacco companies try to stand in the way. No country should ever be intimidated by the threat of a tobacco company lawsuit, and this case will help embolden more nations to take actions that will save lives.

Statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids

This ruling is of global significance because it affirms the sovereign right not only of Uruguay, but of all countries, to protect the health of their citizens by adopting effective measures to reduce tobacco use. It is also a powerful rebuke of Philip Morris, which has abused international trade and investment agreements to challenge strong tobacco control laws in Uruguay and other countries in recent years.

Philip Morris thought it could bully Uruguay into backing down from its strong tobacco control laws and, by doing so, intimidate countries all across the globe. Instead, Uruguay courageously fought back. Uruguay’s refusal to be cowed by Philip Morris and its overwhelming victory demonstrate that all countries, regardless of their size or wealth, can stand up to the tobacco industry and successfully defend their life-saving laws. This ruling should spur countries around the world to quickly and fully implement the World Health Organization Framework Convention on Tobacco Control – a public health treaty that has been ratified by 180 parties. Without strong action now, tobacco will kill one billion people worldwide this century.

The Campaign for Tobacco-Free Kids applauds Uruguay and President Tabaré Vázquez for their courageous leadership in the fight against tobacco, both in enacting strong tobacco control laws and standing up to Philip Morris. The two laws upheld today are part of Uruguay’s comprehensive approach to reducing tobacco use, which also includes a 100 percent smoke-free law, a ban on tobacco advertising and significant tobacco tax increases. Today, youth smoking in Uruguay is at 8 percent, down from 23 percent in 2007.To continue making progress, President Vázquez has announced plans to introduce legislation requiring plain packaging for tobacco products.


Philip Morris challenged Uruguay’s laws as a violation of a bilateral investment treaty between Uruguay andSwitzerland, where Philip Morris is incorporated. The case was heard at the International Centre for Settlement of Investment Disputes, an arbitration panel of the World Bank. The government of Uruguay released the decision today. In addition to ruling in Uruguay’s favor, the panel also ordered Philip Morris to pay Uruguay’s legal costs.

Uruguay’s victory is the latest in a series of legal blows for tobacco companies fighting strong tobacco control measures. In December 2015, an international tribunal threw out a challenge by Philip Morris International toAustralia’s pioneering law requiring that cigarettes be sold in plain packaging, concluding the claim was “an abuse of rights.” In May, the United Kingdom’s High Court upheld that country’s plain packaging law, and the European Union’s Court of Justice upheld new tobacco regulations, including a requirement for large, graphic health warnings and authority for EU countries to adopt plain packaging.

Together, these rulings have created tremendous momentum for global efforts to fight tobacco use and sent a clear message that tobacco companies cannot be allowed to put profits above lives.

Bloomberg Philanthropies and the Campaign for Tobacco-Free Kids provided financial support and technical assistance to the Uruguayan government’s legal team. In 2015, Bloomberg Philanthropies and the Bill & Melinda Gates Foundation also established the Anti-Tobacco Trade Litigation Fund to assist low- and middle-income countries facing similar lawsuits.

Source: Campaign for Tobacco-Free Kids

Written by asiafreshnews

July 12, 2016 at 5:54 pm

Posted in Uncategorized

RHTLaw Taylor Wessing Adds Hong Kong Capabilities with Addition of Hong Kong Law Firm HM Chan & Co

leave a comment »

-Sixth largest law firm in Singapore adds Hong Kong and Greater China capabilities to the growing bench strength and reach of the ASEAN Plus network across Asia. Move comes after successful launch of RHTLaw Taylor Wessing Vietnam.

SINGAPORE/PRNewswire/ — RHTLaw Taylor Wessing LLP (“the Firm”), the sixth largest law firm in Singapore has boosted its presence in Hong Kongand Greater China following an official association with local firm HM Chan & Co inHong Kong.

This association in Hong Kong is the latest addition to RHTLaw Taylor Wessing’s rapidly growing ASEAN Plus Group, a Pan-Asian grouping of leading legal firms. By being an integral part of ASEAN Plus Group, HM Chan & Co opens up unprecedented opportunities for cross-border collaboration between Hong Kong / Greater Chinaand the rest of the Pan-Asian offices in the ASEAN Plus grouping which was launched in 2014. Launching a new office in Hong Kong is part of a series of strategic growth initiatives the firm has planned to bolster presence across ASEAN and North Asia.

Today’s association with HM Chan & Co also adds Hong Kong and Greater China capabilities to the network’s increasing bench strength and reach across the whole of Asia. This latest association with HM Chan & Co comes soon after RHTLaw Taylor Wessing’s successful merger with PBC Partners & RHTLaw on 30 June 2016 to form RHTLaw Taylor Wessing Vietnam. The months ahead will also see Partners from the Singapore office being seconded to Hong Kong and vice versa, a move aimed to boost knowledge transfer and capacity building. The industry areas that will see secondments include:

  1. Banking & Finance
  2. Regulatory Governance
  3. Private Wealth
  4. Intellectual Property and Technology.

Through the association, RHTLaw Taylor Wessing and HM Chan & Co will continue to deliver corporate advisory work with a focus on assisting clients in multi-jurisdictional transactions, a core competence of the team.

Commenting on the association, Tan Chong Huat, Managing Partner, RHTLaw Taylor Wessing said, “This is a very exciting move for our firms and draws on our combined and recognised strengths. We are very pleased to welcome HM Chan & Co into the Taylor Wessing and ASEAN+ network. With the growing volume of transactions flowing between Hong Kong and Singapore, RHTLaw Taylor Wessing sees exciting opportunities for both firms to serve the legal needs of international clients with strategic and business presence in Hong Kong and Mainland China. In addition, with this development, we are also now able to seamlessly serve clients in Singapore with a local Hong Kong and Greater China team. We will also be seconding our Partners to Hong Kong to boost our knowledge and capabilities. This is in line with our aim of helping our clients succeed. I am pleased that this development comes quickly after the successful launch of RHTLaw Taylor Wessing Vietnam.”

The new Hong Kong office further strengthens RHTLaw Taylor Wessing’s already extensive capability acrossAsia, which comprises a network of more than 1050 lawyers in South East Asia operating through its ASEAN+ Group. Internationally, the firm has 33 offices, operating in 20 jurisdictions, across Europe, the Middle East andAsia, with representative offices in the US (Palo Alto and New York). The latest venture in Hong Kong is consistent with RHTLaw Taylor Wessing’s strategy to bolster its service offerings across the region. In the last few years, the Firm has forged strategic alliances with leading Indonesian law firm, Hanafiah Ponggawa and Partners, and South Korean firm DR & AJU, together with several other leading firms in Asia under the ASEAN Plus Group.

About RHTLaw Taylor Wessing LLP

We pride ourselves as a law firm that delivers international capabilities, locally.

Clients of RHTLaw Taylor Wessing can expect intelligent and innovative legal and business solutions from a team that is attuned to the nuances of working in Asia, with the added perspective and expertise of an international firm.

We offer clients access to a network of over 1050 legal professionals across 33 offices in Asia, the Middle Eastand Europe via our membership with Taylor Wessing group. We are also the exclusive Singapore member of The Interlex Group, a global network of leading law firms. In 2014, we launched the ASEAN Plus Group (APG) which is a group of full-services law firms that blends the best of knowledge, culture and international expertise. APG firms have a strong presence in Asia with offices located in Singapore, Indonesia, Vietnam, South Korea,Philippines, Thailand, Taiwan and Malaysia.

Our model is driven by the focus on helping clients succeed, which translates to clear and precise solutions with high-level legal and commercial insights. We proactively grow our practice in tandem with regional and international fast growing industries like Consumer Brands, Education, Energy and Environment, Financial Institution and Services, Life Sciences and Healthcare, Real Estate and Infrastructure and Technology, Media and Communications. These industries complement our core areas of practice in Banking and Finance, Corporate, Capital Markets, Intellectual Property and Technology, Litigation and Dispute Resolution, and Real Estate.

For more information, please go to

About HM Chan & Co

HM Chan & Co is a Hong Kong corporate law firm established by professionals with many years of experience in handling international transactions. The team, led by its founder Mark Chan, comprises Hong Kong qualified lawyers fluent in English, Cantonese and Mandarin, who understand the commercial and financial context of deals and can therefore better help clients achieve their goals in a timely manner.

HM Chan & Co specialise in helping clients at all stages of the business life cycle – from development and seed funding of start-ups via private equity or venture capital investment, to growth and restructuring through public or private M&As, and fund raising through IPOs, secondary listings or equity or debt financing. The team also assists listed companies in their post-listing regulatory and compliance matters, restructurings and investments.

Logo –

Source: RHTLaw Taylor Wessing LLP

Written by asiafreshnews

July 12, 2016 at 5:51 pm

Posted in Uncategorized

MoneyGram Helps to Bring OFWs Closer To Their Families

leave a comment »

-Robin Padilla Continues as Brand Ambassador
MANILA, Philippines, /PRNewswire/ — MoneyGram, a global money transfer company, continues its legacy of connecting consumers to their loved ones with fast and reliable transaction by launching its new global campaign “MoneyGram — Bringing Our Customers Closer”. The remittance company renewed also contract with multi-talented Filipino actor Robin Padilla acting as its global brand ambassador.

Photo –
Logo –

MoneyGram recognizes that modern-day Filipino heroes or “Heroes of the Sea” don’t need to do great feats or wear capes to be called heroes. They battle bouts of loneliness and nostalgia each day as they are separated from their loved ones. At the same time they continuously strive to work hard to be able to provide a better life for their families back in the Philippines. This is already a legitimate reason to salute and celebrate them.

“For more than 70 years, MoneyGram has been helping people around the world and their families to stay connected across borders and boundaries, oceans and countries. It is our honor to be able to assist and support our Overseas Filipino Workers (OFW) in sending money to their loved ones and becoming their bridge to a better life,” says Yogesh Sangle, senior regional director of MoneyGram for Asia & Pacific.

MoneyGram offers global network of approximately 350,000 locations in 200 countries and territories worldwide and more than 12,000 locations across the Philippines. This allows Filipinos to send cash from anywhere in the world.

Receivers can conveniently claim their remittances in the Philippines through trusted partner locations. Additionally, OFW family members can now send their remittances directly to loved ones’ bank accounts at any of the participating 20 banks in the Philippines through MoneyGram’s cash-to-account service.

Each family member plays an active and vital role in pulling the family closer together in the absence of one or both OFW’s parents. The amount of emotional devotion that is required from them is something that both MoneyGram and Robin Padilla admire.

“I am delighted to be a part of MoneyGram once more because I believe in what they stand for. OFWs are there for their family and friends to assist them with every live situation,” shares Padilla.

“MoneyGram’s priority is to connect our consumers with their loved ones by providing convenient and reliable financial connection for life’s essentials and daily needs. We allow them to be as close as possible by providing support and financial needs for their children,” adds Sangle.

With reliable, 10-minute money transfers MoneyGram positively impacts millions of people every day by offering industry leading customer experience at every interaction and an access to financial services for consumers and businesses around the world.

MoneyGram is a leading money transfer company, enables consumers who are not fully served by traditional financial institutions to meet their financial needs. MoneyGram offers bills payment services in the United States and Canada and money transfer services worldwide through a global network of more than 347,000 agent locations — including retailers, international post offices and financial institutions — in 198 countries and territories. To learn more about money transfer or bill payment at an agent location or online, please visit or connect via Facebook

Media Contact:
Maria Bankiet-Kaminska
p: +48 22 377 2185

Source: MoneyGram
Related stocks: NASDAQ-NMS:MGI
Related Links:

Written by asiafreshnews

July 12, 2016 at 3:45 pm

Posted in Uncategorized

CH2M Shares Innovative Water Solutions at 2016 Singapore International Water Week

leave a comment »

DENVER, Colo., /PRNewswire/ — CH2M is pleased to announce its participation as a founding sponsor in the Singapore International Water Week, hosted by Singapore’s National Water Agency, PUB, from July 10-14, in Singapore. The biennial event gathers stakeholders from the global water industry to share best practices, showcase the latest technologies and tap business opportunities.

Photo –
Logo –

“Singapore International Water Week provides an important venue for thought leadership and idea exchange on the integration of water and the development of more sustainable cities now and in the future, and CH2M is once again proud to participate, sharing our expertise on water resilient cities and innovative water technology solutions,” said Peter Nicol, CH2M Global Water Business Group President. “CH2M has worked with PUB for more than 20 years, and we look forward to continuing to support Singapore and the region’s investment in innovative water solutions to advance the country and serve as a model for other nations.”

CH2M executives and technologists are speaking on a variety of topics during the Singapore International Water Week, including benefits of implementing mainstream deammonification, maximizing opportunities in process design and operations, among other topics. A highlight of the convention is Nicol’s keynote address on Effective Water Management: A Core Business Strategy for Industry, taking place on July 12, during the Water Convention Keynote Plenary. Mr. Nicol shares insights on how to keep pace with the growing industrial water market in this Water and Wastewater International article.

Additionally, CH2M Vice President and Global Operations Director Bryan Harvey, CH2M President Global Business Groups Greg McIntyre and CH2M Vice President, Technology Senior Fellow and Global Wastewater Service Team Leader Julian Sandino are participating and speaking during the Water Leaders Summit. Bringing together global water industry leaders, government regulators and policy think-tanks, participants will discuss water in the urban context, delving into critical issues such as water accessibility, sustainability and supply resilience in cities, following the theme “Water and Cities: Pathways to Sustainability and Resilience.” Specifically, Mr. Harvey, Mr. McIntyre and Mr. Sandino will host a discussion on The New Rules of Water Infrastructure and Technologies. The session will highlight the wide range of technologies and solutions available to city planners and the water industry, sparking conversations on innovative solutions to creating water resilient cities and using wastewater as a resource.

CH2M has a strong local presence in Singapore. For more than two decades, the firm has supported PUB on implementing major water infrastructure projects, including serving as programme manager and designer for the Deep Tunnel Sewerage System, which won the ‘Water Project of the Year’ at the Global Water Intelligence Global Awards in 2009; the Changi Water Reclamation Plant, one of the world’s largest water reclamation plants; and PUB’s Active, Beautiful, Clean Waters (ABC Waters) programme, which launched in April 2006 and has helped transform the water bodies in Singapore beyond their utilitarian functions, creating new community spaces, as well as a higher quality of living in Singapore. PUB honored CH2M with its Watermark Award earlier this year for its legacy of advocating water sustainability through community outreach activities and partnership on numerous milestone projects that lead the way in the area of water stewardship and encourage the community to take ownership of Singapore’s water resources, helping contribute to its water sustainability.

Learn about CH2M’s water solutions and more during the Singapore International Water Week by visiting CH2M’s booth #L10.

About CH2M
CH2M leads the professional services industry delivering sustainable solutions benefiting societal, environmental and economic outcomes with the development of infrastructure and industry. In this way, CH2Mers make a positive difference providing consulting, design, engineering and management services for clients in water; environment and nuclear; transportation; energy and industrial markets, from iconic infrastructure to global programmes like the Olympic Games. Ranked among the World’s Most Ethical Companies and top firms in environmental consulting and programme management, CH2M in 2016 became the first professional services firm honored with the World Environment Center Gold Medal Award for efforts advancing sustainable development. Connect with CH2M at; LinkedIn; Twitter; and Facebook.

Lori Irvine
CH2M (Water Business Group)
+1 720 286 3137

Source: CH2M
Related Links:

Written by asiafreshnews

July 12, 2016 at 3:43 pm

Posted in Uncategorized

Japanese Smartphone Users Fail to Recognise Importance of Mobile Security, Reports ESET

leave a comment »

SINGAPORE /PRNewswire/ — ESET®, a global pioneer in proactive protection for more than two decades, today released data showing that Japanese smartphone users could be making themselves vulnerable to the threat of cybercrime, by failing to take simple security precautions while on-the-go.

The findings from the ESET Japan Cyber-Savviness Report 2016, showed that despite smartphone users in Japan being some of the most knowledgeable in Asia-Pacific when it comes to cybersecurity, this does not necessarily lead to safer online behaviour.

The survey highlighted that while most smartphone users in Japan know they should take security measures like regularly updating their operating system (75%), only installing apps from trusted sources (67%), and changing passwords regularly (60%), very few actually follow these best practices.

Results showed that over half of all Japanese smartphone users (56.3%) believe that a PC is more likely to be hacked as compared to a mobile device, which explains why so few respondents in Japan proactively download security solutions onto their smartphones. Results highlighted that only a tiny 22 percent of Japanese respondents use credible paid-for security solutions to protect their smartphone, and only 35 percent use free antivirus software.

“Japan is known to be one of the most advanced consumer technology markets in Asia-Pacific, yet there is still a mismatch between what the smartphone users in Japan know they ‘should do’ versus what they ‘actually do’. It’s a myth that PCs and laptops are more likely to be targeted by cybercriminals than mobile devices. Users should start to recognise that their smartphones are like mini computers that are just as powerful as PCs, and in most cases store highly sensitive information that is extremely valuable to cybercriminals,” said Lukas Raska, COO Asia-Pacific, at ESET.

Mr Raska adds, “It takes small steps to making sure you have security software in place to protect against attacks or keeping your passwords regularly updated would make a huge difference when it comes to staying safe online.”

ESET polled 1,033 respondents in Japan to gain insights into the attitudes, knowledge and user behaviour there when it comes to cybersecurity. The study showed that while users in Japan are knowledgeable about cybersecurity and take few risks online, they still have some way to go in ensuring that they’re adequately protected from online threats. Cyber-savviness is based on factors such as users’ knowledge or ability to understand activities that are likely to make them vulnerable online, risky behaviours while surfing the web, and the proactive steps they can take to protect themselves online.

More information about the ESET Japan Cyber-Savviness Report 2016 can be found here.

The ESET Asia Cyber-Savviness Report 2015, covering six Asian markets, and the ESET Vietnam Cyber-Savviness Report 2015 can also be found online.

About ESET

ESET®, a pioneer in proactive protection and the creator of the award-winning ESET NOD32® technology, is a global provider of security solutions for businesses and consumers. For over 26 years, the company has continued to lead the industry in proactive threat detection. ESET NOD32 technology won its 80th VB100 award in June 2013, reinforcing its position as holder of a record number of Virus Bulletin “VB100” Awards; it has never missed a single “In-the-Wild” worm or virus since the inception of testing in 1998. In addition, ESET NOD32 technology holds the longest consecutive string of the VB100 awards of any AV vendor. ESET has also received a number of accolades from AV-Comparatives, AV-TEST and other testing organizations and reviews. ESET NOD32® Antivirus, ESET Smart Security®, ESET Cyber Security® (solution for Mac), ESET® Mobile Security and ESET’s IT security solutions for business are trusted by millions of global users and are among the most recommended security solutions in the world.

ESET recently updated its two-factor authentication (2FA) application, adding a secure validation to weak and static user passwords. This updated version of ESET’s 2FA application provides flexibility and deeper integration of 2FA into bespoke applications, making it the best, most cost-effective solution for SMBs everywhere.

The company has its global headquarters in Bratislava (Slovakia), with regional distribution centers in San Diego (US), Buenos Aires (Argentina), and Singapore; and offices in Jena (Germany), Prague (Czech Republic) and Sao Paulo (Brazil). ESET has malware research centers in Bratislava, San Diego, Buenos Aires, Singapore, Prague, Kosice (Slovakia), Krakow (Poland), Montreal (Canada), Moscow (Russia) and an extensive partner network covering more than 180 countries. More information is available from the ESET Press Center.

Source: ESET

Written by asiafreshnews

July 12, 2016 at 3:37 pm

Posted in Uncategorized

SUEZ Launches AQUADVANCED(R) Urban Drainage, an Innovative Solution to Optimise the Performance of Sewer and Stormwater Networks and Preserve the Natural Environment

leave a comment »

SINGAPORE  /PRNewswire/ — Faced with urban population growth, global warming and changing regulations, optimising the performance of sewer and stormwater networks is a priority for local authorities. Responding to this challenge, SUEZ is launching AQUADVANCED® Urban Drainage[1], a digital solution that allows local authorities to monitor in real time their sewer and stormwater networks to mitigate the risk of flooding and to control the quality of discharges into the natural environment.


Rising urbanisation and the increase of impermeable surfaces in urban areas have reduced the natural infiltration of stormwater into the soil to 15%. The remaining 85% flows on the surface, collecting the residues deposited on roofs and roads (fuel, heavy metals, plastics, etc.). Local authorities are faced with the challenge of collecting these polluted waters in the sewerage networks, and of treating them later into wastewater treatment plants to reduce the risks of severe flooding, human and material damage and pollution of the natural ecosystem. Stormwater is responsible for 50% of the pollution flowing into rivers and beaches in urban areas.


In response to these challenges, SUEZ is launching AQUADVANCED® Urban Drainage, a digital solution that helps local authorities to manage their sewer and stormwater systems. The tool allows to choose the solution that best meets their needs, from the monitoring of an environment (rivers, the sea, sewerage networks), to the anticipation of flooding events and pollution of the natural environment, and the predictive and dynamic management of the complete sewerage system.

AQUADVANCED® Urban Drainage provides a global, real-time vision of the complete system, based on data from sensors installed both in the network and in the environment (rivers, watercourses, etc.) and on short-term weather forecasts. By centralising and analysing all these data, the software solution can anticipate the hydraulic performance of the network (saturated storage capacities, volumes to be treated, etc.) or of the natural ecosystem (risk of pollution or overflowing watercourses). For certain sewerage systems, the tool can also calculate the best control strategy, and automatically and remotely monitor the system’s facilities (storage reservoirs, pumping stations, etc.).

AQUADVANCED® Urban Drainage anticipates the risk of untreated wastewater overflowing into the natural ecosystem, monitors the quality of discharge on a daily basis and helps to protect the environment. Deploying this system can cut the volumes of stormwater that flow into rivers or the sea by up to 45%.

Presented at the Singapore International Water Week (10-14 July), where it is currently being deployed, AQUADVANCED® Urban Drainage has been already introduced in eight European cities, including Bordeaux, the Paris conurbation, Marseille and Barcelona.

Leader on the Smart Water market in Europe, SUEZ is complementing its offer to support local authorities in the sustainable management of resources with this management software dedicated to optimise sewer and stormwater networks’ performance. AQUADVANCED® Urban Drainage completes the existing software offer for the drinking water networks, named AQUADVANCED® Water Networks.


We are at the dawn of the resource revolution. Faced with an increasing world population, growing urban development and rarefied resources, the security, optimisation and recovery of resources are indispensable to our future. SUEZ (Paris: SEV, Brussels: SEVB) supplies 92 million people with drinking water and 65 million with sanitation services, collects waste from almost 34 million people, recovers 16 million tonnes of waste per year and generates 5,855 GWh of local and renewable energy. With 82,530 employees, SUEZ, which is present on all five continents, is a key player in the sustainable management of resources. SUEZ generated total revenues of €15.1 billion in 2015.


SUEZ has been present for over 60 years in South East Asia and 40 years in Greater China in water and waste management. With 9,500 employees and over 50 joint ventures with local partners, SUEZ is supporting authorities and industries in developing innovative solutions to address climate change and sustainable resource management. The Group built over 420 water and wastewater treatment plants in Asia, supplying drinking water to 20 million people. It operates China’s first PPP water contract in Macau. It is also the leader of waste management in Hong Kong and delivers its expertise in the management of environmental services to 11 industrial parks. In 2015, SUEZ managed revenues of over €1 billion generated by its activities in Asia.

Press Contacts:

SUEZ Paris

Catherine des Arcis
Tel: +33 1 58 810 54 23


Tel: +853 6681 4700

[1] AQUADVANCED® is a registered trademark or a trademark under pending application.

Source: SUEZ

Written by asiafreshnews

July 12, 2016 at 2:28 pm

Posted in Uncategorized